Monday, November 3, 2014

Botox maker Allergan Inc, which is fending off an acquisition by Valeant Pharmaceuticals Inc , said on Monday that it had been approached by another party regarding a potential transaction.The company is Actavis Plc, a source familiar with the situation said.Allergan, which made the disclosure in a regulatory filing on Monday, had said it was looking for acquisitions but has not previously said it had been contacted about a deal.Valeant and Pershing Square Capital Management, which owns nearly a 10 percent stake in Allergan, made an offer now worth $55 billion for Allergan at the end of April.

Shares of ACT traded higher by 2.17% or $5.26/share to $248.00. In the past year, the shares have traded as low as $153.42 and as high as $249.94. On average, 2407010 shares of ACT exchange hands on a given day and today's volume is recorded at 1259400.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.89% or $1.69/share to $191.75. In the past year, the shares have traded as low as $88.34 and as high as $192.98. On average, 2403670 shares of AGN exchange hands on a given day and today's volume is recorded at 1907521.

Please Donate

Article Archive

The reports on this site are for information purposes only and are not a recommendation for the purchase of securities. The information contained in these reports have been gathered from sources we believe to be reliable, however, we make no guarantee as to the accuracy or completeness to such information.